175 related articles for article (PubMed ID: 16116306)
1. High rates of primary Mycobacterium avium complex and Pneumocystis jiroveci prophylaxis in the United States.
Gebo KA; Fleishman JA; Reilly ED; Moore RD;
Med Care; 2005 Sep; 43(9 Suppl):III23-30. PubMed ID: 16116306
[TBL] [Abstract][Full Text] [Related]
2. Surveillance for AIDS-defining opportunistic illnesses, 1992-1997.
Jones JL; Hanson DL; Dworkin MS; Alderton DL; Fleming PL; Kaplan JE; Ward J
MMWR CDC Surveill Summ; 1999 Apr; 48(2):1-22. PubMed ID: 12412613
[TBL] [Abstract][Full Text] [Related]
3. Underuse of primary Mycobacterium avium complex and Pneumocystis carinii prophylaxis in the United States.
Asch SM; Gifford AL; Bozzette SA; Turner B; Mathews WC; Kuromiya K; Cunningham W; Andersen R; Shapiro M; Rastegar A; McCutchan JA
J Acquir Immune Defic Syndr; 2001 Dec; 28(4):340-4. PubMed ID: 11707670
[TBL] [Abstract][Full Text] [Related]
4. Racial and gender disparities in receipt of highly active antiretroviral therapy persist in a multistate sample of HIV patients in 2001.
Gebo KA; Fleishman JA; Conviser R; Reilly ED; Korthuis PT; Moore RD; Hellinger J; Keiser P; Rubin HR; Crane L; Hellinger FJ; Mathews WC;
J Acquir Immune Defic Syndr; 2005 Jan; 38(1):96-103. PubMed ID: 15608532
[TBL] [Abstract][Full Text] [Related]
5. Gender differences in quality of HIV care in Ryan White CARE Act-funded clinics.
Hirschhorn LR; McInnes K; Landon BE; Wilson IB; Ding L; Marsden PV; Malitz F; Cleary PD
Womens Health Issues; 2006; 16(3):104-12. PubMed ID: 16765286
[TBL] [Abstract][Full Text] [Related]
6. Prophylaxis for opportunistic infections among HIV-infected patients receiving medical care.
Sackoff J; McFarland J; Su S; Bryan E
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Dec; 19(4):387-92. PubMed ID: 9833748
[TBL] [Abstract][Full Text] [Related]
7. The rate of serious bacterial infections among HIV-infected children with immune reconstitution who have discontinued opportunistic infection prophylaxis.
Nachman S; Gona P; Dankner W; Weinberg A; Yogev R; Gershon A; Rathore M; Read JS; Huang S; Elgie C; Hudgens K; Hughes W
Pediatrics; 2005 Apr; 115(4):e488-94. PubMed ID: 15772172
[TBL] [Abstract][Full Text] [Related]
8. Hospital and outpatient health services utilization among HIV-infected children in care 2000-2001.
Rutstein RM; Gebo KA; Siberry GK; Flynn PM; Spector SA; Sharp VL; Fleishman JA
Med Care; 2005 Sep; 43(9 Suppl):III31-9. PubMed ID: 16116307
[TBL] [Abstract][Full Text] [Related]
9. Prescription of Pneumocystis Jiroveci Pneumonia Prophylaxis in HIV-Infected Patients.
Lin X; Garg S; Mattson CL; Luo Q; Skarbinski J
J Int Assoc Provid AIDS Care; 2016 Nov; 15(6):455-458. PubMed ID: 27629868
[TBL] [Abstract][Full Text] [Related]
10. Hospital and outpatient health services utilization among HIV-infected adults in care 2000-2002.
Fleishman JA; Gebo KA; Reilly ED; Conviser R; Christopher Mathews W; Todd Korthuis P; Hellinger J; Rutstein R; Keiser P; Rubin H; Moore RD;
Med Care; 2005 Sep; 43(9 Suppl):III40-52. PubMed ID: 16116308
[TBL] [Abstract][Full Text] [Related]
11. Joint effects of HIV-1 RNA levels and CD4 lymphocyte cells on the risk of specific opportunistic infections.
Williams PL; Currier JS; Swindells S
AIDS; 1999 Jun; 13(9):1035-44. PubMed ID: 10397533
[TBL] [Abstract][Full Text] [Related]
12. The cost-effectiveness of preventing AIDS-related opportunistic infections.
Freedberg KA; Scharfstein JA; Seage GR; Losina E; Weinstein MC; Craven DE; Paltiel AD
JAMA; 1998 Jan; 279(2):130-6. PubMed ID: 9440663
[TBL] [Abstract][Full Text] [Related]
13. Discontinuation of primary prophylaxis against Mycobacterium avium complex infection in HIV-infected persons receiving antiretroviral therapy: observations from a large national cohort in the United States, 1992-2002.
Brooks JT; Song R; Hanson DL; Wolfe M; Swerdlow DL;
Clin Infect Dis; 2005 Aug; 41(4):549-53. PubMed ID: 16028167
[TBL] [Abstract][Full Text] [Related]
14. Disseminated mycobacterium avium-intracellulare complex (MAC) infection in the era of effective antiretroviral therapy: is prophylaxis still indicated?
Lange CG; Woolley IJ; Brodt RH
Drugs; 2004; 64(7):679-92. PubMed ID: 15025543
[TBL] [Abstract][Full Text] [Related]
15. Incidence of disseminated Mycobacterium avium-complex infection in HIV patients receiving antiretroviral therapy with use of Mycobacterium avium-complex prophylaxis.
Jung Y; Song KH; Choe PG; Park WB; Bang JH; Kim ES; Kim HB; Park SW; Kim NJ; Oh MD
Int J STD AIDS; 2017 Dec; 28(14):1426-1432. PubMed ID: 28592210
[TBL] [Abstract][Full Text] [Related]
16. Is primary mycobacterium avium complex prophylaxis necessary in patients with CD4 <50 cells/μL who are virologically suppressed on cART?
Yangco BG; Buchacz K; Baker R; Palella FJ; Armon C; Brooks JT;
AIDS Patient Care STDS; 2014 Jun; 28(6):280-3. PubMed ID: 24833016
[TBL] [Abstract][Full Text] [Related]
17. Is it safe to discontinue primary Pneumocystis jiroveci pneumonia prophylaxis in patients with virologically suppressed HIV infection and a CD4 cell count <200 cells/microL?
; Mocroft A; Reiss P; Kirk O; Mussini C; Girardi E; Morlat P; Stephan C; De Wit S; Doerholt K; Ghosn J; Bucher HC; Lundgren JD; Chene G; Miro JM; Furrer H
Clin Infect Dis; 2010 Sep; 51(5):611-9. PubMed ID: 20645862
[TBL] [Abstract][Full Text] [Related]
18. Opportunistic infections update.
Proj Inf Perspect; 1999 Apr; (27):19-20. PubMed ID: 11366735
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy.
Kaplan JE; Hanson D; Dworkin MS; Frederick T; Bertolli J; Lindegren ML; Holmberg S; Jones JL
Clin Infect Dis; 2000 Apr; 30 Suppl 1():S5-14. PubMed ID: 10770911
[TBL] [Abstract][Full Text] [Related]
20. Patterns of diagnoses in hospital admissions in a multistate cohort of HIV-positive adults in 2001.
Betz ME; Gebo KA; Barber E; Sklar P; Fleishman JA; Reilly ED; Christopher Mathews W;
Med Care; 2005 Sep; 43(9 Suppl):III3-14. PubMed ID: 16116304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
